| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-09 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-08 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.21 | 1e-06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.27 | 2e-06 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-06 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.28 | 3e-06 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-06 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |